Literature DB >> 34849635

How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?

Kate M Mitchell1,2, Mathieu Maheu-Giroux3, Dobromir Dimitrov4, Mia Moore4, James P Hughes4,5, Deborah Donnell4, Chris Beyrer6, Wafaa M El-Sadr7, Myron S Cohen8, Marie Claude Boily1,2.   

Abstract

The plan for Ending the HIV (human immunodeficiency virus) Epidemic (EHE) in the United States aims to reduce new infections by 75% by 2025 and by 90% by 2030. For EHE to be successful, it is important to accurately measure changes in numbers of new HIV infections after 5 and 10 years (to determine whether the EHE goals have been achieved) but also over shorter timescales (to monitor progress and intensify prevention efforts if required). In this viewpoint, we aim to demonstrate why the method used to monitor progress toward the EHE goals must be carefully considered. We briefly describe and discuss different methods to estimate numbers of new HIV infections based on longitudinal cohort studies, cross-sectional incidence surveys, and routine surveillance data. We particularly focus on identifying conditions under which unadjusted and adjusted estimates based on routine surveillance data can be used to estimate changes in new HIV infections.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; estimates; incidence surveys; infections; surveillance data

Mesh:

Year:  2022        PMID: 34849635      PMCID: PMC9403299          DOI: 10.1093/cid/ciab976

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   20.999


  22 in total

1.  High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.

Authors:  Frank Tanser; Till Bärnighausen; Erofili Grapsa; Jaffer Zaidi; Marie-Louise Newell
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

2.  Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America.

Authors:  Mia Moore; Marie-Claude Boily; Kate M Mitchell; Deborah D Donnell; Myron S Cohen; Dobromir T Dimitrov
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-01       Impact factor: 3.731

3.  Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study.

Authors:  Jessica Justman; Jason B Reed; George Bicego; Deborah Donnell; Keala Li; Naomi Bock; Alison Koler; Neena M Philip; Charmaine K Mlambo; Bharat S Parekh; Yen T Duong; Dennis L Ellenberger; Wafaa M El-Sadr; Rejoice Nkambule
Journal:  Lancet HIV       Date:  2016-11-16       Impact factor: 12.767

4.  Using Primer-ID Deep Sequencing to Detect Recent Human Immunodeficiency Virus Type 1 Infection.

Authors:  Ann M Dennis; Shuntai Zhou; Christopher J Sellers; Emily Learner; Marc Potempa; Myron S Cohen; William C Miller; Joseph J Eron; Ronald Swanstrom
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

5.  Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina.

Authors:  Shuntai Zhou; Sabrina Sizemore; Matt Moeser; Scott Zimmerman; Erika Samoff; Victoria Mobley; Simon Frost; Andy Cressman; Michael Clark; Tara Skelly; Hemant Kelkar; Umadevi Veluvolu; Corbin Jones; Joseph Eron; Myron Cohen; Julie A E Nelson; Ronald Swanstrom; Ann M Dennis
Journal:  J Infect Dis       Date:  2021-03-03       Impact factor: 5.226

6.  Estimated HIV incidence in the United States, 2006-2009.

Authors:  Joseph Prejean; Ruiguang Song; Angela Hernandez; Rebecca Ziebell; Timothy Green; Frances Walker; Lillian S Lin; Qian An; Jonathan Mermin; Amy Lansky; H Irene Hall
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

7.  HIV Trends in the United States: Diagnoses and Estimated Incidence.

Authors:  H Irene Hall; Ruiguang Song; Tian Tang; Qian An; Joseph Prejean; Patricia Dietz; Angela L Hernandez; Timothy Green; Norma Harris; Eugene McCray; Jonathan Mermin
Journal:  JMIR Public Health Surveill       Date:  2017-02-03

8.  Maintaining HIV care during the COVID-19 pandemic.

Authors:  Hongbo Jiang; Yi Zhou; Weiming Tang
Journal:  Lancet HIV       Date:  2020-04-06       Impact factor: 12.767

9.  HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay.

Authors:  P Soodla; R Simmons; K Huik; M Pauskar; E-L Jõgeda; H Rajasaar; E Kallaste; M Maimets; R Avi; G Murphy; K Porter; I Lutsar
Journal:  HIV Med       Date:  2017-08-01       Impact factor: 3.180

10.  Sexual behaviour, changes in sexual behaviour and associated factors among women at high risk of HIV participating in feasibility studies for prevention trials in Tanzania.

Authors:  Diana Faini; Claudia Hanson; Kathy Baisley; Saidi Kapiga; Richard Hayes
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

View more
  1 in total

1.  Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study.

Authors:  Carla M Doyle; Joseph Cox; Rachael M Milwid; Raphaël Bitera; Charlotte Lanièce Delaunay; Michel Alary; Gilles Lambert; Cécile Tremblay; Sharmistha Mishra; Mathieu Maheu-Giroux
Journal:  J Int AIDS Soc       Date:  2022-09       Impact factor: 6.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.